搜索优化
English
全部
搜索
图片
视频
地图
资讯
Copilot
更多
购物
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
排序方式
最佳匹配
最新鲜
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
资讯
6 天
FDA取消自体CAR-T细胞免疫疗法风险评估与缓解策略(REMS)
2025年6月27日美国食品药品监督管理局 (FDA)宣布,取消当前已获批的BCMA及CD19靶向自体嵌合抗原受体 (CAR)T细胞免疫疗法的风险评估与缓解策略 (risk evaluation and mitigation strategy,REMS)要求。FDA认定无需REMS即可确保此类免疫疗法的安全性与有效性。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Central Texas flash floods
X CEO resigns
Former Hasbro CEO dies
New Mexico flooding
Loan interest to restart
Sentenced to 8+ years
Six agents suspended
Hits $4 trillion market cap
Harvard faces subpoenas
To buy Verona Pharma
14th Wimbledon semifinal
Won't revive immigration law
Russia batters Ukraine
American Kennel Club sued
Threatens 50% Brazil tariff
Trump admin sues California
Ex-doctor refuses to answer
Sends more tariff letters
Cases hit highest level
Midair collision in Manitoba
Christian Horner sacked
Suffers serious injuries
Sinner defeats Shelton
5-yr extension w/ Thunder
Interim NASA administrator
US sanctions UN official
Confirmed to lead FAA
Cracker sandwiches recalled
Barbie with Type 1 diabetes
Former Gov. DiPrete dies
Cyclist LeMond honored
Announces anti-graft plan
Death ruled a homicide
反馈